Vaxcyte (PCVX) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Vaxcyte (PCVX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 313M (+29.22%) | 242M (+15.31%) | 210M (+8.11%) | 194M (+31.09%) | 148M (+10.87%) | 134M (+14.26%) | 117M (-11.08%) | 132M (+39.03%) | 95M (-9.18%) | 104M (+6.91%) | 97M (+34.02%) | 73M (+25.15%) | 58M (+12.49%) | 52M (+8.28%) | 48M (+23.94%) | 38M (+21.43%) | 32M (+37.32%) | 23M (+12.92%) | 20M (+15.75%) | 18M (+2.26%) | 17M (+17.74%) | 15M (-10.66%) | 16M (-9.74%) | 18M (-25.25%) | 24M (-6.50%) | 26M (+170.09%) | 9.63M (-3.41%) | 9.97M | - |
Selling General And Administrative | 33M (+2.64%) | 32M (-0.71%) | 32M (+1.28%) | 32M (-1.90%) | 33M (+14.36%) | 29M (+24.23%) | 23M (+7.08%) | 21M (+7.94%) | 20M (+13.46%) | 18M (+12.30%) | 16M (+7.95%) | 14M (+10.30%) | 13M (+9.71%) | 12M (+9.63%) | 11M (+15.71%) | 9.42M (+24.93%) | 7.54M (+11.37%) | 6.77M (+3.83%) | 6.52M (+7.24%) | 6.08M (+3.23%) | 5.89M (+22.96%) | 4.79M (-2.24%) | 4.90M (+60.66%) | 3.05M (-7.01%) | 3.28M (-13.00%) | 3.77M (+50.20%) | 2.51M (+11.06%) | 2.26M | - |
Operating Expenses | 346M (+26.09%) | 274M (+13.16%) | 242M (+7.14%) | 226M (+25.13%) | 181M (+11.48%) | 162M (+15.90%) | 140M (-8.54%) | 153M (+33.64%) | 114M (-41.80%) | 197M (+74.01%) | 113M (+29.70%) | 87M (+22.42%) | 71M (-17.77%) | 87M (+47.78%) | 59M (+22.32%) | 48M (+22.11%) | 39M (+31.39%) | 30M (+10.76%) | 27M (+13.57%) | 24M (+2.55%) | 23M (+18.97%) | 19M (-8.73%) | 21M (+0.42%) | 21M (-23.12%) | 28M (-7.32%) | 30M (+145.30%) | 12M (-0.74%) | 12M | - |
Depreciation And Amortization | 2.95M (-78.05%) | 13M | - | - | 2.96M (+5.71%) | 2.80M (+55.56%) | 1.80M (+28.57%) | 1.40M (+40.00%) | 1.00M (+19.05%) | 840K (+5.00%) | 800K (0.00%) | 800K (+12.68%) | 710K (-25.26%) | 950K (+35.71%) | 700K (+16.67%) | 600K (+3.45%) | 580K (+28.89%) | 450K (-10.00%) | 500K (0.00%) | 500K (+42.86%) | 350K (+9.38%) | 320K (+6.67%) | 300K (-25.00%) | 400K (+5.26%) | 380K (-39.68%) | 630K (+110.00%) | 300K (0.00%) | 300K | - |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -345.85M (+26.09%) | -274.28M (+13.16%) | -242.38M (+7.14%) | -226.22M (+25.13%) | -180.79M (+11.48%) | -162.17M (+15.90%) | -139.92M (-8.54%) | -152.98M (+33.64%) | -114.47M (-41.80%) | -196.68M (+74.01%) | -113.03M (+29.70%) | -87.15M (+22.42%) | -71.19M (-17.77%) | -86.57M (+47.78%) | -58.58M (+22.32%) | -47.89M (+22.11%) | -39.22M (+31.39%) | -29.85M (+10.76%) | -26.95M (+13.57%) | -23.73M (+2.55%) | -23.14M (+18.97%) | -19.45M (-8.73%) | -21.31M (+0.42%) | -21.22M (-23.12%) | -27.60M (-7.32%) | -29.78M (+145.30%) | -12.14M (-0.74%) | -12.23M | - |
Ebit | -345.85M (+26.09%) | -274.28M (+13.16%) | -242.38M (+7.14%) | -226.22M (+25.13%) | -180.79M (+11.48%) | -162.17M (+15.90%) | -139.92M (-8.54%) | -152.98M (+33.64%) | -114.47M (-41.80%) | -196.68M (+74.01%) | -113.03M (+29.70%) | -87.15M (+22.42%) | -71.19M (-17.77%) | -86.57M (+47.78%) | -58.58M (+22.32%) | -47.89M (+22.11%) | -39.22M (+31.39%) | -29.85M (+10.76%) | -26.95M (+13.57%) | -23.73M (+2.55%) | -23.14M (+18.97%) | -19.45M (-8.73%) | -21.31M (+0.42%) | -21.22M (-23.12%) | -27.60M (+71.32%) | -16.11M (+32.70%) | -12.14M (-0.74%) | -12.23M (-10.53%) | -13.67M |
EBITDA | -342.90M (-2.04%) | -350.04M (+64.47%) | -212.83M (+27.77%) | -166.57M (-6.34%) | -177.84M (+11.60%) | -159.36M (+15.38%) | -138.12M (-8.88%) | -151.58M (+33.59%) | -113.47M (-42.06%) | -195.83M (+74.49%) | -112.23M (+29.97%) | -86.35M (+22.52%) | -70.48M (-17.68%) | -85.62M (+47.93%) | -57.88M (+22.39%) | -47.29M (+22.39%) | -38.64M (+31.47%) | -29.39M (+11.12%) | -26.45M (+13.86%) | -23.23M (+1.89%) | -22.80M (+19.18%) | -19.13M (-8.95%) | -21.01M (+0.91%) | -20.82M (-23.48%) | -27.21M (+75.78%) | -15.48M (+30.74%) | -11.84M (-0.75%) | -11.93M (-12.73%) | -13.67M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Interest Income | 27M (+0.60%) | 26M (-9.60%) | 29M (-5.83%) | 31M (-5.68%) | 33M (-9.65%) | 36M (+29.94%) | 28M (+17.85%) | 24M (+9.88%) | 22M (+23.34%) | 18M (-5.03%) | 19M (+12.46%) | 16M (+58.33%) | 10M (+56.71%) | 6.63M (+457.14%) | 1.19M (+197.50%) | 400K (+207.69%) | 130K (+30.00%) | 100K (+11.11%) | 90K (0.00%) | 90K (+50.00%) | 60K (+100.00%) | 30K (0.00%) | 30K (-25.00%) | 40K (-71.43%) | 140K (-57.58%) | 330K (+175.00%) | 120K (-33.33%) | 180K | - |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K | - | - | - | - | 10K (-50.00%) | 20K (+100.00%) | 10K (0.00%) | 10K | - |
Net Interest Income | 27M (+0.60%) | 26M (-9.60%) | 29M (-5.83%) | 31M (-5.68%) | 33M (-9.65%) | 36M (+29.94%) | 28M (+17.85%) | 24M (+9.88%) | 22M (+23.34%) | 18M (-5.03%) | 19M (+12.46%) | 16M (+58.33%) | 10M (+56.71%) | 6.63M (+457.14%) | 1.19M (+197.50%) | 400K (+207.69%) | 130K (+30.00%) | 100K (+11.11%) | 90K (0.00%) | 90K (+50.00%) | 60K (+100.00%) | 30K (0.00%) | 30K (-25.00%) | 40K (-69.23%) | 130K (-58.06%) | 310K (+181.82%) | 110K (-35.29%) | 170K | - |
Other Non Operating Income | -1.38M | 37M (+12772.41%) | 290K (-98.98%) | 29M (+300.14%) | 7.14M | -4.37M | 8.74M (+1759.57%) | 470K | -2.21M | 2.87M (-85.90%) | 20M (+8.24%) | 19M (+75.30%) | 11M (+22.35%) | 8.77M (+1228.79%) | 660K | -650.00K | 240K (-93.31%) | 3.59M (+955.88%) | 340K (+580.00%) | 50K (-97.40%) | 1.92M (+433.33%) | 360K (+24.14%) | 290K (-67.78%) | 900K (+100.00%) | 450K (-88.40%) | 3.88M (+373.17%) | 820K (-47.77%) | 1.57M | - |
Net Income | |||||||||||||||||||||||||||||
Net Income From Continuing Operations | -320.62M (+30.06%) | -246.51M (+15.82%) | -212.83M (+27.77%) | -166.57M (+18.37%) | -140.72M (+2.66%) | -137.08M (+32.93%) | -103.12M (-19.88%) | -128.70M (+35.45%) | -95.02M (-47.44%) | -180.80M (+95.12%) | -92.66M (+35.59%) | -68.34M (+13.03%) | -60.46M (-22.54%) | -78.05M (+34.75%) | -57.92M (+19.35%) | -48.53M (+24.47%) | -38.99M (+36.52%) | -28.56M (+7.33%) | -26.61M (+12.37%) | -23.68M (+11.59%) | -21.22M (+2.31%) | -20.74M (-1.33%) | -21.02M (+3.44%) | -20.32M (-25.13%) | -27.14M (+85.64%) | -14.62M (+29.15%) | -11.32M (+6.19%) | -10.66M (-22.02%) | -13.67M |
Net Income | -320.62M (+30.06%) | -246.51M (+15.82%) | -212.83M (+27.77%) | -166.57M (+18.37%) | -140.72M (+2.66%) | -137.08M (+32.93%) | -103.12M (-19.88%) | -128.70M (+35.45%) | -95.02M (-47.44%) | -180.80M (+95.12%) | -92.66M (+35.59%) | -68.34M (+13.03%) | -60.46M (-22.54%) | -78.05M (+34.75%) | -57.92M (+19.35%) | -48.53M (+24.47%) | -38.99M (+36.52%) | -28.56M (+7.33%) | -26.61M (+12.37%) | -23.68M (+11.59%) | -21.22M (+2.31%) | -20.74M (-1.33%) | -21.02M (+3.44%) | -20.32M (-25.13%) | -27.14M (+85.64%) | -14.62M (+29.15%) | -11.32M (+6.19%) | -10.66M (-22.02%) | -13.67M |
Comprehensive Income Net Of Tax | -329.04M (-56.77%) | -761.17M (+262.31%) | -210.09M (+24.95%) | -168.14M (+22.58%) | -137.17M (-70.69%) | -467.98M (+346.55%) | -104.80M (-19.25%) | -129.78M (+40.59%) | -92.31M (-77.02%) | -401.73M (+334.63%) | -92.43M (+30.35%) | -70.91M (+18.08%) | -60.05M (-73.14%) | -223.60M (+287.72%) | -57.67M (+18.66%) | -48.60M (+22.79%) | -39.58M (-60.55%) | -100.32M (+276.86%) | -26.62M (+12.61%) | -23.64M (+11.14%) | -21.27M (-76.16%) | -89.22M (+324.45%) | -21.02M (+3.44%) | -20.32M (-25.13%) | -27.14M (-46.01%) | -50.27M | - | - | - |